Grifols S.A. Q3 2025 Results Summary (Form 6-K)

Grifols reported strong operational delivery, continuing its Value Creation Plan.

• Financial Performance:

  • Q3 Revenues: EUR 1,865M (+9.1% cc).
  • 9M Adjusted EBITDA: EUR 1,358M (+11.2% cc), margin reached 24.5%.
  • Group Profit (9M): EUR 304M, up 245% YoY.

• Balance Sheet & Cash Flow:

  • Leverage Ratio declined to 4.2x (down from 5.1x PY).
  • Q3 Free Cash Flow pre-M&A: EUR 203M.
  • Liquidity remains robust at EUR 1,475M.

• Strategic Drivers: Growth led by Biopharma